Related Experiment Video
Updated: May 8, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Exposure to Type 1 and Type 2 Maternal Diabetes is Associated with Stage 3-5 Retinopathy of Prematurity
Adam Lewis1, Isaac Bakis2, Alexa Love3
1Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.
Insights
Maternal diabetes, including type 1 and type 2, significantly increases the risk of vision-threatening retinopathy of prematurity (ROP) in infants. Early screening for ROP in infants exposed to maternal diabetes is crucial for preserving vision.
Area of Science:
- Neonatal ophthalmology
- Perinatal medicine
- Endocrinology
Background:
- Retinopathy of prematurity (ROP) and diabetic retinopathy share pathological similarities.
- Maternal hyperglycemia in utero may increase infant ROP risk.
- Previous studies on this association yielded conflicting results and did not differentiate DM subtypes.
Purpose of the Study:
- To clarify the association between maternal diabetes mellitus (DM) and ROP progression.
- To investigate the impact of maternal DM subtypes on infant ROP risk.
- To adjust for significant comorbidities in the analysis.
Main Methods:
- Retrospective cohort study of preterm infants (<31 weeks GA or <1500 g BW) from 2004-2021.
- Data from Vanderbilt Neonatal Clinical Repository and chart review.
- Multivariate logistic regression adjusted for GA, BW, sex, race, year, location, and comorbidities.
Main Results:
- Stage 3-5 ROP was significantly associated with maternal DM (OR 3.04).
- Both type 1 DM (T1DM) (OR 6.36) and type 2 DM (T2DM) (OR 5.82) were associated with increased ROP risk.
- Lower birth weight and gestational age were linked to more severe ROP.
Conclusions:
- Maternal diabetes (T1DM and T2DM) increases infant risk for vision-threatening ROP.
- Infant BW and GA may not accurately reflect ROP progression risk in diabetic pregnancies.
- Incorporate maternal DM status into ROP screening protocols to preserve infant vision.
Purpose:
Pathologic similarities between retinopathy of prematurity (ROP) and diabetic retinopathy, leading causes of blindness, suggest that in utero exposure to maternal hyperglycemia may influence an infant's risk of ROP progression to vision-threatening stages. Prior studies exploring this association yielded conflicting results and did not explore maternal diabetes mellitus (DM) subtypes. We aim to clarify these associations while adjusting for significant comorbidities.
Design:
Retrospective cohort study.
Participants:
Preterm infants born at <31 weeks gestational age (GA) or <1500 g birth weight (BW) receiving care at Vanderbilt University Medical Center's Neonatal Intensive Care Unit between 2004 and 2021 with documented ROP staging and maternal diabetes status.
Methods:
Review of data from the Vanderbilt Neonatal Clinical Repository supplemented by chart review. Data analyzed by descriptive statistics of prevalence, BW, and GA for the cohorts as well as through multivariate logistic regression analyses with ROP stage and maternal diabetes as dependent and independent variables while adjusting for GA, BW, sex, race, year of birth, birth center location, necrotizing enterocolitis, intraventricular hemorrhage, and bronchopulmonary dysplasia. Infants with ROP stage 3-5 were considered cases, and those with ROP stage 0 were used as controls.
Main Outcome Measures:
The association between exposure to maternal diabetes and the presence of stage 3-5 versus stage 0 ROP.
Results:
Two thousand one hundred twenty-one (68%) infants had stage 0 ROP, and 311 (10%) had stage 3-5 ROP. Maternal DM prevalence was 9% and resulted in higher BW and GA in premature infants. Lower BW and GA were associated with more severe ROP. Stage 3-5 ROP was significantly associated with maternal DM (odds ratio [OR] 3.04, 95% confidence interval [CI]: 1.67-5.45, P = 0.000218), including type 1 DM (T1DM) (OR 6.36, 95% CI 1.29-28.29, P = 0.0174) and type 2 DM (T2DM) (OR 5.82, 95% CI 2.06-15.71, P = 0.00066).
Conclusions:
Our results suggest that maternal diabetes, including T1DM and T2DM, increase an infant's risk of developing vision-threatening ROP. The BW and GA profiles of infants with maternal diabetes may provide false reassurance regarding their risk of progression. Considering maternal DM exposure in screening decisions (inclusion and intervals) may help to preserve vision in at-risk infants.
Financial Disclosures:
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Retinopathy
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Introduction

